In chronic HIV infection, most untreated patients lose naive CD4 + and CD8 + T-cells while a minority preserves them despite persistent high viremia. While antiretroviral therapy (ART)-mediated viral suppression generally results in a rise of naive and total CD4 + T cells, certain patients experience very little or no T-cell reconstitution. High peripheral T cell activation has been linked to poor clinical outcomes, interfering with previous evaluations of thymic function in disease progression and therapy-mediated T-cell recovery. To circumvent this, we used the sj/βTREC ratio, a robust index of thymopoiesis that is independent of peripheral T cell proliferation, to evaluate the thymic contribution to the preservation and restoration of naive CD4 + T cells. We show that the loss of naïve and total CD4 + T cells is the result of or is exacerbated by a sustained thymic defect, while efficient thymopoiesis supports naive and total CD4 + T-cell maintenance in slow progressor patients. In ART-treated patients, CD4 + T-cell recovery was associated with the normalization of thymopoiesis, while the thymic defect persisted in aviremic patients who failed to recover CD4 + T-cell counts. Overall, we demonstrate that efficient thymopoiesis is key in the natural maintenance and in therapy-mediated recovery of naive and total CD4 + T cells.
Introduction
A hallmark of human immunodeficiency virus 1 (HIV-1) infection is the progressive loss of CD4 + T cells, which ultimately leads to severe immunodeficiency. The contraction of the CD4 + T-cell population reflects the sum of shifts between de novo production, proliferation, differentiation and death of thymic emigrants, naive, effector and memory T cells 1 . Indeed, while a vast majority of the gut-associated short-lived CCR5+ CD4+ activated T cells are depleted during acute HIV infection [2] [3] [4] , a commonly observed immune perturbation is the reduction of the naïve T cell compartment within blood as disease progresses 5 . The exact mechanisms underlying this change is likely the result of a combination of direct and indirect cytopathogenicity, disorganization of lymphoid organs, heightened immune activation and/or loss of thymic function 6 . Nevertheless, HIV-1-induced CD4 + T-cell lymphopenia evokes the need for the replenishment of lymphocyte numbers through an input of naive CD4 + T cells. This can be accomplished through proliferation and expansion of the pre-existing pool of naive CD4 + T cells 7 or through de novo thymic production, with the latter leading to the establishment of a CD4 + Tcell pool with various T-cell receptors. The relative contribution of proliferation and thymic output to the size of the CD4 + T-cell compartment in treated and untreated chronic HIV infection remains uncertain.
T-cell receptor excision circle (TREC) frequencies at HIV-1 seroconversion have been closely associated with the hazard of death. 8 However, it is nevertheless important to note that these observed low TREC values may not only be a result of suppression of thymic activity, but could also reflect heightened immune activation and proliferation, which also have been related to poor prognosis. [9] [10] [11] [12] Thus, in resolving this issue, the sjTREC frequency is not a suitable marker of thymic function, particularly in HIV-infected patients. We recently developed a new tool to estimate thymic activity, based on the measurement of the extent of intrathymic precursor T-cell proliferation occurring between late TN and early DP thymocyte differentiation stages that is proportional to thymic output. Since DJβTRECs (byproducts of the TCRB rearrangement) are generated before this proliferation, DJβTREC frequency in DP cells is inversely proportional to the number of division cycles these cells have undergone during their differentiation process.
Moreover, since the sjTREC molecule is produced after this extensive proliferation, the sjTRECs are not diluted by this intrathymic cell division. Accordingly, the sj/βTREC ratio (sjTREC frequency/DJβTREC frequency), measured in peripheral blood mononuclear cells, is a direct measure of the proliferative history of recent thymic emigrants and represents the extent of thymic output over the preceding weeks. Using this tool, we have demonstrated that HIV-1 infection generally suppresses thymic activity as early as three months post-infection in untreated subjects. 13 Following the administration of HAART, the majority of patients experience viral suppression and a concomitant increase in CD4 + naive and memory T-cell numbers, 14 while some patients (8-17%) fail to reconstitute their CD4 + T-cell numbers despite viral control. 15, 16 During this immune reconstitution, radiographic evidence of thymic tissue, greater TREC levels and reduced peripheral T-cell activation are closely associated with the extent of naive T cell restoration. [17] [18] [19] [20] This suggests, but does not prove, that the thymus plays an important role in the repopulation of the CD4 + T-cell pool. If thymic output determines the magnitude of cellular restoration, it would be expected that the lack of such thymic activity would result in a poor immunological response to HAART despite control of viremia.
In the present study, the sj/βTREC ratio-a robust index of thymic activity-along with Ki-67 staining to measure naive T cell entry into cell cycle were used to decipher the relative contributions of thymic output and peripheral proliferation to CD4 + and CD8 + naive T-cell homeostasis during the natural history of HIV infection as well as during HAART-induced immune reconstitution. antigen-or cytokine-driven or homeostatic proliferation) and thymic output to the maintenance of both naive (CD45RA + CD27 + ) and total CD4 + T-cell counts.
Despite sustained viral replication (see table 1 ) and an inverted CD4/CD8 T cell ratio, SLP patients maintained normal or near-normal proportions and absolute numbers of circulating CD4 + and CD8 + naive T cells ( figure 1 ). This contrasts to what was observed in patients who progress more rapidly to disease (group P), where naive T-cell proportions in the CD4 + compartment as well as the absolute number of naive CD4 + T cells were reduced when compared to these numbers in uninfected, healthy, age-matched individuals (p=0.003 and p=0.001 respectively; figure 1 ). This was also the case for the CD8 + T-cell compartment (p=0.007 and p=0.007).
Although a greater naive T-cell depletion cannot be excluded in these patients, the fact that we observed a significant decrease in both CD4 + and CD8 + naive T-cell counts suggests the possibility of a thymic defect in P patients.
Maintenance of the naive T cell compartment in untreated viremic patients: thymic output or peripheral proliferation?
The maintenance of peripheral naive T-cell numbers rests upon the thymus's ability to produce new T cells, on their survival and on the magnitude of their peripheral proliferation. We thus sought to determine and compare the level of proliferation of naive T cells in both groups through figure 2B ). These results indicate that in rapid progressors, high levels of cell-cycle entry and activation, shown by a greater proportion of Ki-67 expressing cells, are insufficient to maintain naive and total CD4 + T-cell numbers.
The depletion of both CD4 + and CD8 + naive T cells in P patients argues for a defect in thymic output. We therefore assessed thymic function through determination of the intrathymic precursor T-cell proliferation by quantification of the sj/βTREC ratio. Intrathymic precursor T-cell proliferation was significantly reduced in group P as compared to healthy individuals (median sj/βTREC ratio = 12.6 versus 22; means: 15.7 versus 50.3; p=0.05) ( figure 2C ). In SLP patients, however, the sj/βTREC ratio was similar to that of healthy controls (median sj/βTREC ratio =33.4; mean = 88.8; p=N.S.). Since thymic function is age dependant, 18, 23 we analyzed the sj/βTREC ratio in both viremic patient groups (P and SLP) as a function of age. This analysis revealed that a majority of P patients (8/10) consistently showed a sj/βTREC ratio below the average level of age-matched healthy individuals whereas the sj/βTREC ratio values obtained in SLP patients bracketed the normal range for all age groups ( figure 2D ). Hence, thymic function is significantly greater in viremic patients who maintain CD4 + T-cell counts than in patients who have progressed more rapidly to disease (p=0.02) ( figure 2C ). These data demonstrate that in the absence of efficient thymopoeiesis-the enhanced cell cycling observed in progressor patientsis not able to maintain naive T-cell numbers while, in slow progressors, efficient thymopoiesis seems sufficient to maintain CD4 + T-cell counts.
Modification of naive T cell homeostasis during chronic HIV infection
In a previous study 13 we demonstrated that despite a reduced thymic function and an increased peripheral naive T-cell proliferation, patients' sjTREC levels during primary HIV infection remained similar to those of healthy individuals. Moreover, the DJβTREC frequencies were significantly higher in these patients than in uninfected control subjects. These data suggested that a peripheral mechanism was initiated during primary HIV infection to compensate for the impairment of thymic function, allowing the maintenance of peripheral naive CD4 + T-cell counts. 13 When analyzing these two types of TRECs in chronically infected patients, we observed a strong reduction of sjTREC frequencies in group P as compared to frequencies in both SLP patients and healthy controls, with the latter two being comparable (median sjTREC = 46/10 figure 2F ). These data suggest that the compensatory mechanism that maintains stable sjTREC frequencies and increased DJβTREC frequencies observed in primary infection is lost in chronic progressor patients. On the other hand, this peripheral compensatory mechanism is not needed in SLP patients given that the naive T-cell pool is maintained, and supported by efficient thymopoiesis.
All these indices were affected regardless of age in the untreated P patients, illustrating that, chronic HIV infection disrupts thymic productivity and naive T-cell homeostasis independently of age. Importantly, these experiments show that such disruptions are not present in SLP patients, thereby stressing the role of thymic activity in maintaining CD4 + T-cell counts despite high viremia.
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Antiretroviral treatment leads to increased counts but not to increased proportions of naive T cells in immunological responders, while poor immunological responders do not restore either.
HIV-infected individuals differ in their capacity to reconstitute CD4 + T-cell numbers following HAART-mediated viral suppression. While the majority of patients do exhibit a significant rise in CD4 + T-cell numbers, some patients maintain low CD4 + T-cell counts despite adequate viral control (8-17%). 15, 16 In order to test whether differences in the kinetic and magnitude of immune reconstitution in these groups of patients could be attributed to perturbations in thymic output and/or peripheral T-cell proliferation, we analyzed two groups of HAART treated, virologicallysuppressed patients (table 1) (table 1) .
In immunological responders, antiretroviral treatment leads to greater CD4 + naive T-cell counts (figure 3B) than those found in P patients (p=0.004) after a median of 22 months of treatment. Of note, although clearly significant, this restoration was only partial inasmuch as the circulating naive CD4 + T-cell counts did not reach the level of those in healthy controls (p=0.004). However, the naive T-cell frequencies within the CD4 + and CD8 + compartments remained similar to those of untreated patients (p=0.8), demonstrating that the naive T-cell niche disrupted in progressor patients is not completely restored following viral suppression ( figure 3A and B) .
In contrast, in the PIR group, the influence of viral suppression differed on naïve T-cell restoration. While both the frequency of naive T cells within the CD4 + compartment and the absolute number of naive CD4 + T cells remained similar to those of untreated patients (figure 3), a significant increase was observed in both the frequency (p=0.06) and absolute counts of CD8 + naive T cells (p=0.013; figure 3 ).
Recovery of the naive T-cell compartment in patients under HAART: thymic output or peripheral proliferation?
To assess the relative contribution of naive T-cell cycling and thymic output to the efficiency of immune reconstitution, we measured Ki-67 along with the sj/βTREC ratio as a measure of intrathymic precursor T-cell proliferation in the two groups of virologically-suppressed patients (IR and PIR). These numbers were compared to those observed for untreated progressors (group P).
The frequency of CD4 + and CD8 + naive T cells expressing Ki-67 was strongly reduced in group IR as compared to group P (4-fold in CD4 + and 6-fold in CD8 + naive T cells; p=0.0037 p=0.0015 respectively), returning to levels similar to those observed in healthy controls ( figure 4A and B).
In contrast, naive T-cell Ki-67 expression in poor immunological responders remained high following viral suppression. These data suggest that the observed cell-cycle entry of peripheral naive T cells in these patients is not dependent on plasma viremia, but may reflect the expansion of the remaining cells needed to fill the void left by peripheral T-cell lymphopenia, as has been reported in other lymphopenic settings. [24] [25] [26] Thymic production, as measured by the quantification of the sj/βTREC ratio, was greatest in IR patients (median sj/βTREC ratio = 76.6 as compared to 12.6 in group P; mean= 147.4 versus 15.8; p=0.002) (figure 4C), at levels even greater than those of healthy controls (median sj/βTREC ratio=22; mean= 50.3; p=0.01). In contrast, the thymic function of PIR patients remained similar to that of group P (median sj/βTREC ratio=9.8; mean= 20.6), clearly demonstrating that these patients do not restore thymic function despite viral suppression. Figure   4D further clarifies this point and illustrates how the sj/βTREC ratio is particularly low in the younger PIR individuals.
With IR patients exhibiting greater thymic function, one would expect greater levels of sjTRECs than among healthy controls. Individual TREC quantification showed, however, that sjTREC levels were similar in both treated patient groups and controls (figure 4E), with DJβTRECs frequencies significantly lower in the IR group patients (median DJβTREC=5. Impact of thymic function and peripheral proliferation on naive CD4 + T-cell counts.
We then sought to evaluate the relative impact of de novo production from the thymus and peripheral proliferation on the number of both CD4 + and CD8 + naive T cells in the four groups of patients. By analyzing all samples from HIV-infected patients, for which both thymic function and FACS analysis were performed (n=29), a strong positive correlation was observed between thymic production, as measured by the sj/βTREC ratio, and CD4 + naive T-cell counts (R=0.504, p=0.009) ( figure 6A ). Although the correlation was less pronounced in the CD8 + compartment, a trend was also observed between naive T-cell counts and intrathymic proliferation (R=0.336, p=0.08- figure 5A ). In contrast, peripheral naive CD4 + T-cell cycling negatively correlates with naive CD4 + T-cell counts (R=-0.646; p=0.0002- figure 6B ). On the other hand, peripheral proliferation of naive CD8 + T cells was not linked to naive CD8 + T-cell counts (figure 6B).
These analyses suggest that thymopoiesis is the main source of T-cell production in treated or untreated HIV-1 infected individuals. The efficiency of thymic function is crucial to both maintaining naive T-cell counts in slow progressor HIV-infected patients and restoring CD4 + Tcell counts in treated patients. In contrast, naive T cell peripheral cycling, either induced in response to CD4 + lymphopenia as previously observed in other lymphopenic settings [24] [25] [26] or as a consequence of immune activation, does not help in restoring peripheral naive T-cell counts.
Discussion
In this report, we have evaluated thymic function as well as cell cycling in homogeneous groups of patients with divergent responses to persistent viremia or who differentially reconstitute CD4 + T-cell numbers following viral suppression under HAART. We show that during chronic HIV-1 infection, a defect in intrathymic precursor T-cell proliferation is a rate-limiting step that governs the maintenance of naive CD4 + and CD8 + T-cell counts. Indeed, by comparing two similarly viremic groups with distinct CD4 + T-cell outcomes, we have found that the inability to generate new T cells in the thymus is a key element in disease progression. In addition, we have demonstrated that the speed of CD4 + T-cell reconstitution in patients with HAART-mediated viral suppression is linked to their capacity to efficiently restore de novo naive T-cell production through efficient thymopoiesis. In contrast, the negative correlation observed between Ki-67 expression and naive T-cell numbers illustrates the inability of naive T-cell cycling to rescue low CD4 + T-cell numbers.
Variation of the sjTREC frequency alone does not accurately reflect the perturbations of thymic function in HIV-infected patients. Indeed, changes in sjTREC frequencies can be the consequence of either or both reduced thymic production and increased peripheral proliferation as a consequence of generalized immune activation. 12, 18, 27, 28 On the other hand, the sj/βTREC ratio exclusively depends upon intrathymic precursor T-cell proliferation and is not affected by changes in the frequency of peripheral T cells in cycle, or their survival or death rate. 13 As the extent of thymic export relies mainly on the number of cells reaching positive and negative selection steps, variations in precursor T-cell proliferation are certainly reflected by modifications in thymic production. 29 The sj/βTREC ratio is thus an accurate marker for thymic output, even during chronic HIV infection when generalized immune activation strongly enhances peripheral T-cell proliferation.
Slow disease progression has been shown to be related to both viral and host factors such as viral deficiency (nef-, Vpr-Vif-…), 30, 31 tropism (lack of drift to CXCR4 tropic viruses) 32 and particular genotypes (mutations in CCR5, CCR2, SDF1) 33 or HLA type (HLA-A3, -B14, -B17, -B27, -DR6 and DR7). 33 Moreover, it has been argued that recurrent or persistent immune activation also leads to disease progression. 4, 34 However, the viremic, slow-progressing patients studied here harbor higher proportions of Ki-67 + than healthy individuals in both naive ( figure 2) and effector/memory T cells (data not shown). With this in mind, our results demonstrate for the first time that a specific characteristic of viremic, slow-progressor patients is a good thymic function (figure 2), most likely enabling the maintenance of CD4 + T-cell counts despite active viral replication. Lastly, the fact that the slowly-progressing patients exhibit a slow CD4 + T-cell loss in the presence of high level viremia excludes an inherent reduced replicative capacity of the virus as a cause of slow disease progression.
Upon initiation of HAART, T-cell reconstitution in HIV-infected patients occurs in two major
phases. The first takes place within the first months of treatment, and is characterized mainly by an upsurge of circulating memory CD4 + T cells largely redistributed from lymphoid tissue and the normalization of T-cell activation. 14, 35, 36 Although an increase in sjTRECs has been observed in this first phase of immune reconstitution, the differential sjTREC frequency changes in lymph nodes and peripheral blood suggest that redistribution of TREC-rich cells also occurs in this early phase of HAART. 37 This is followed by a second phase of effective T-cell reconstitution under
HAART that takes place during the subsequent year, when naive T cells steadily rise. 35 This naive T-cell increase has been shown to correlate with a positive change in thymic size, accompanied by an increase in sjTREC frequency and absolute sjTREC content. [38] [39] [40] The question of whether the rise in sjTRECs was a direct consequence of thymic output remained controversial since a reduction in immune T-cell activation, halting the suspected heightened TREC dilution before HAART, was shown to precede these events. 14, 41 The analysis of the sj/βTREC ratio within this second reconstitution phase allowed us to definitively prove that immunological responders demonstrate a significant supra-normal thymic activity (figure 4C and D) during this reconstitution phase.
Interestingly, despite reduced thymic activity, peripheral naive CD4 + T-cell counts never completely recovered in immunological responders during the course of this study ( figure 3B ).
Moreover even with strong intrathymic proliferation ( figure 4C and 4D ) and very little naive Tcell cycling (figure 4A and 4B), the sjTREC levels remained nearly identical to those observed in uninfected healthy controls ( figure 4E ). Thus, the TREC-bearing cells must either be recruited to the effector and memory T-cell pool (followed by proliferation) or selectively die. 14 Both of these scenarios ultimately prevent the increase in sjTREC levels, as might be expected from the greater sj/βTREC ratio, and limit naive T-cell count restoration ( figure 3A and 3B) . The lack of naive Tcell survival potential has been also observed in other immune reconstitution settings. For
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Patients and Methods

Patients and control individuals
Blood samples were obtained from 38 healthy volunteers (control group) and 49 HIV-1 infected patients in the chronic phase of infection. Peripheral blood mononuclear cells (PBMCs) were isolated by ficoll hypaque density sedimentation, frozen and stored for further use. A summary of the virological and immunological status of these patients is shown in Table 1 . Twenty-two highly-viremic HIV-infected patients did not receive therapy by preference or following medical recommendation. They were grouped according to CD4 + T-cell counts into progressor (P, n=10) and slow progressor (SLP, n=12) patients. The other 27 patients receiving HAART had undetectable plasma viral load at the time of sampling and were subcategorized into two groups according to their rate of CD4 + T-cell reconstitution: 14 immunological responders (IR); and 13
poor immunological responders (PIR). In all HAART-treated patients, sampling was done during the well-described secondary phase of CD4 + T recovery, a median of 22 months after HAART initiation. Although six patients in the PIR group exhibited minor blips of viremia during the follow-up period, most patients had an undetectable viral load throughout this same period. Due to sample availability, only subgroups of patients from SLP and PIR groups were FACS analyzed. However, these subgroups were similar to their respective patient populations as well as to P and IR groups respectively with respect to age and viral load. 
Flow cytometry
Frozen PBMC were thawed and resuspended in PBS 2%FCS. Approximately 2-3x10e6 cells were stained for surface expression of CD3, CD4, CD8, CD45RA and CD27 (Becton Dickinson, Pharmingen). This was followed by fixation/permeabilization by using the BD FACSLysing and 
TREC quantification
As previously described, 13, 42, 49 Statistical differences between groups are shown on top (*: p<0.05; **: p<0.01). The subgroups of patients analyzed are representative of their respective patient population described in Table 1 with respect to age, CD4 counts and viral load. Table 1 with respect to age, CD4 counts and viral load. Table 1 
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